Tilray Inc (NASDAQ:TLRY - Get Free Report) shares were up 1.3% during trading on Tuesday . The company traded as high as $1.60 and last traded at $1.60. Approximately 4,121,774 shares were traded during mid-day trading, a decline of 83% from the average daily volume of 24,889,479 shares. The stock had previously closed at $1.58.
Analyst Upgrades and Downgrades
Separately, Roth Mkm lowered their target price on Tilray from $2.00 to $1.75 and set a "neutral" rating on the stock in a report on Friday, October 11th.
View Our Latest Report on TLRY
Tilray Price Performance
The company has a market cap of $1.54 billion, a price-to-earnings ratio of -6.33 and a beta of 2.13. The company has a current ratio of 2.47, a quick ratio of 1.57 and a debt-to-equity ratio of 0.08. The business has a 50-day moving average price of $1.73 and a 200 day moving average price of $1.80.
Tilray (NASDAQ:TLRY - Get Free Report) last announced its earnings results on Thursday, October 10th. The company reported ($0.04) EPS for the quarter, meeting the consensus estimate of ($0.04). The business had revenue of $200.00 million during the quarter, compared to the consensus estimate of $218.70 million. Tilray had a negative return on equity of 2.00% and a negative net margin of 26.79%. Tilray's revenue was up 13.0% compared to the same quarter last year. During the same period in the prior year, the business posted ($0.10) earnings per share. As a group, research analysts expect that Tilray Inc will post -0.14 earnings per share for the current fiscal year.
Hedge Funds Weigh In On Tilray
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in TLRY. HighPoint Advisor Group LLC purchased a new stake in shares of Tilray in the fourth quarter valued at $43,000. Madrona Financial Services LLC acquired a new stake in Tilray during the 1st quarter worth about $124,000. SpiderRock Advisors LLC purchased a new position in Tilray during the 1st quarter valued at about $247,000. Private Advisor Group LLC increased its holdings in shares of Tilray by 7.3% in the 1st quarter. Private Advisor Group LLC now owns 175,845 shares of the company's stock valued at $434,000 after purchasing an additional 12,021 shares during the period. Finally, Mirae Asset Global Investments Co. Ltd. lifted its position in shares of Tilray by 8.7% in the first quarter. Mirae Asset Global Investments Co. Ltd. now owns 2,679,532 shares of the company's stock worth $6,699,000 after purchasing an additional 213,834 shares in the last quarter. Institutional investors and hedge funds own 9.35% of the company's stock.
About Tilray
(
Get Free Report)
Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.
Recommended Stories
Before you consider Tilray, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tilray wasn't on the list.
While Tilray currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link below to learn more about using beta to protect yourself.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
